EHC Encompass Health


Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

ESG term mentions

In last year of SEC filings
Base YearClimate ChangeCoralEnvironmentEnvironmentalEnvironmental ProtectionIntensityMaterialsNatureOffsetPackagePandemicResiliencyWasteWastewaterWaterWater UsageAccessBenefitsBlackCalifornia Consumer Privacy ActCharitableCharityCommunityCultureCustomerCyberCyber SecurityCybersecurityData PrivacyDeathDemographicDemographicsDisabilityDiversityDiversity and InclusionEmployeeEmployee EngagementEmployee RetentionEngagementEthnicEthnicityGenderHealth and SafetyHealth CareHealthcareHiringHuman CapitalHuman ResourcesIncidentInjuriesInjuryMinorityOpioidPerquisitesPrivacyRacismRecruitRecruitmentReimbursementResource GroupRetentionRetirementSafetySatisfactionSkillSkilledSkillsSocialSocietalStakeholderSupplierSupplier DiversitySupply ChainTalentTrainingUnionViolenceVolunteerWomenWorkersWorkforceAssessmentAssuranceAttorneys GeneralAuditBoard OversightBoard RefreshmentBonusChronicClassifiedCommitmentConflict of InterestCorporate GovernanceCorporate PurposeCorruptionDepartment ofEnterprise Risk ManagementERMESGEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIncentivizeIndependenceIndependentInnovationInnovativeInvestigationLawsuitLead Independent DirectorLeadershipLitigationLong-termMajorityMaterialityOverseeOversightPerquisitePlaintiffPledgingPoison PillPolitical SpendingProcurementPurposeRecoupReputationReputationalResearch and DevelopmentResponsibilityResponsibleSpecial MeetingStewardshipStockholder EngagementStrategySustainabilitySustainableTargetsTaxTenureTerm LimitTransparencyVoting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On May 6, 2021, Encompass Health Corporation (the “Company”) held its 2021 annual meeting of stockholders (the “Annual Meeting”) at During the Annual Meeting, the stockholders of the Company voted on the following proposals:

1.election of all 14 persons nominated by the Company’s board of directors;

2.ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm; and

3.approval of the compensation of the Company’s named executive officers, as disclosed in the proxy statement filed on March 26, 2021 pursuant to the compensation disclosure rules of the Securities and Exchange Commission.

As of the record date for the Annual Meeting, there were 99,551,380 shares of the Company’s common stock issued and outstanding. Each share of common stock was entitled to one vote on each matter properly brought before the Annual Meeting. The common stock voted together as a class. Votes representing 90.2% of the combined voting power of the common stock were represented by proxy at the Annual Meeting.

The final voting results for the Annual Meeting were as follows:

•Proposal 1, election of directors, each of the nominees was elected:

Name of NomineeVotes ForVotes


Greg D. Carmichael84,277,600 565,843 38,095
John W. Chidsey82,698,023 2,144,561 38,954
Donald L. Correll82,808,043 2,038,008 35,487
Yvonne M. Curl82,104,942 2,742,722 33,874
Charles M. Elson82,672,491 2,172,880 36,167
Joan E. Herman84,671,871 172,845 36,822
Leo I. Higdon, Jr.82,342,166 2,503,628 35,744
Leslye G. Katz84,166,948 679,462 35,128
Patricia A. Maryland84,708,044 140,407 33,087
John E. Maupin, Jr.82,771,015 2,074,569 35,954
Nancy M. Schlichting84,691,120 155,519 34,899
L. Edward Shaw, Jr.81,987,877 2,858,298 35,363
Mark J. Tarr83,963,766 881,469 36,303
Terrance Williams84,705,930 136,947 38,661

•Proposal 2, ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm, passed:

Votes ForVotes AgainstVotes Abstained

•Proposal 3, approval of the compensation of the Company’s named executive officers, passed:

Votes ForVotes AgainstVotes Abstained

Proposals 1 and 3 each received 4,956,209 broker non-votes. There were no broker non-votes on Proposal 2.